Product Description

🔹 Product Overview
BDPARP 150 mg Tablet is a prescription targeted anticancer medicine used in the treatment of specific cancers associated with DNA repair gene mutations.
Contains Olaparib 150 mg, a PARP (Poly ADP-Ribose Polymerase) inhibitor that helps slow the growth and spread of cancer cells.
Commonly prescribed for the treatment and maintenance therapy of certain ovarian, breast, pancreatic, and prostate cancers.

🔹 Key Uses
Treatment of ovarian cancer
Management of HER2-negative breast cancer with BRCA mutations
Treatment of selected pancreatic cancers
Management of metastatic prostate cancer
Maintenance therapy for eligible patients with genetic mutations affecting DNA repair pathways.

🔹 Composition
Active ingredient: Olaparib 150 mg
Therapeutic class: Anti-neoplastic / Anticancer medicine
Drug category: PARP inhibitor

🔹 How It Works
Blocks PARP enzymes that help cancer cells repair damaged DNA.
Prevents cancer cells from recovering from genetic damage.
Leads to cancer cell death while helping slow tumor progression.

🔹 Key Benefits
Advanced targeted cancer therapy
Helps delay disease progression
Supports long-term cancer management in eligible patients
Oral tablet formulation for convenient administration
Widely used in precision oncology treatment strategies.

🔹 Dosage and Administration
Take exactly as prescribed by an oncologist.
Swallow tablets whole with water.
Can be taken with or without food.
Do not crush, chew, or split the tablets.
Take doses at the same time each day for optimal effectiveness.

🔹 Possible Side Effects
Nausea
Vomiting
Fatigue
Diarrhea
Loss of appetite
Anemia
Headache
Dizziness
Decreased blood cell counts

🔹 Precautions
Use only under specialist oncology supervision.
Regular blood tests may be required during treatment.
Avoid grapefruit and grapefruit juice.
Effective contraception is recommended during and after treatment as advised by your doctor.
Inform your healthcare provider about all medicines and supplements being used.